Role of Cathepsin K in bone invasion of pituitary adenomas: A dual mechanism involving cell proliferation and osteoclastogenesis
- 5 January 2025
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 611, 217443
Abstract
No abstract availableKeywords
All Related Versions
This publication has 52 references indexed in Scilit:
- Unveiling autophagy complexity in leukemia: The molecular landscape and possible interactions with apoptosis and ferroptosisCancer Letters, 2023
- PA suppresses antitumor immunity of T cells by disturbing mitochondrial activity through Akt/mTOR-mediated Ca2+ fluxCancer Letters, 2023
- mTOR inhibitor, gemcitabine and PD-L1 antibody blockade combination therapy suppresses pancreatic cancer progression via metabolic reprogramming and immune microenvironment remodeling in Trp53flox/+LSL-KrasG12D/+Pdx-1-Cre murine modelsCancer Letters, 2022
- Overview of the 2022 WHO Classification of Pituitary TumorsEndocrine Pathology, 2022
- Targeting cathepsin K diminishes prostate cancer establishment and growth in murine boneJournal of Cancer Research and Clinical Oncology, 2019
- The Prognostic Roles of the Ki-67 Proliferation Index, P53 Expression, Mitotic Index, and Radiological Tumor Invasion in Pituitary AdenomasEndocrine Pathology, 2019
- Inhibition of Osteoclast Differentiation by Ginsenoside Rg3 in RAW264.7 Cells via RANKL, JNK and p38 MAPK Pathways Through a Modulation of Cathepsin K: An In Silico and In Vitro StudyPhytotherapy Research, 2015
- Ribosomal Protein S6 Phosphorylation2015
- Hyaluronan inhibits TLR-4 dependent cathepsin K and matrix metalloproteinase 1 expression in human fibroblastsBiochemical and Biophysical Research Communications, 2013
- Inhibition of osteoclast differentiation and bone resorption by cathepsin K antisense oligonucleotidesMolecular Carcinogenesis, 2001